Eliza Slawther's profile photo

Eliza Slawther

London

Senior Writer at The Pink Sheet

Senior writer at @PharmaPinkSheet for @citeline.

Featured in: Favicon informa.com (+3) Favicon dailymail.co.uk Favicon standard.co.uk Favicon warringtonguardian.co.uk Favicon mancunion.com Favicon chemistanddruggist.co.uk Favicon apmhealtheurope.com Favicon citeline.com (+1)

Articles

  • EU Pharma Reform: Council Proposal A ‘Step In The Right Direction’ But ‘More Work To Be Done’

    1 day ago | insights.citeline.com | Eliza Slawther

    EU Pharma Reform: Council Proposal A ‘Step In The Right Direction’ But ‘More Work To Be Done’Experts from EUCOPE explain why the Council of the EU’s position on the proposed overhaul of the general pharmaceutical legislation could offer more predictability for companies than the commission’s initial offering. The overhaul of the EU pharma legislation has passed another milestone (Shutterstock)

  • UK MHRA: Bacteriophage Developers Wanted ‘More Clarity’ On UK Framework

    2 days ago | insights.citeline.com | Eliza Slawther

    UK MHRA: Bacteriophage Developers Wanted ‘More Clarity’ On UK FrameworkJulian Beach, interim executive director of healthcare quality and access at the UK drug regulator, the MHRA, tells the Pink Sheet how the agency is responding to increased efforts to develop bacteriophage therapies. The MHRA released its bacteriophage guidance on 4 June (Shutterstock)

  • MHRA Backs Bacteriophage Innovation To Fight Antimicrobial Resistance

    3 days ago | insights.citeline.com | Eliza Slawther

    MHRA Backs Bacteriophage Innovation To Fight Antimicrobial ResistanceThe UK regulator wants to help companies to develop bacteriophages for the treatment of infections. Its first guidance on this topic offers advice to researchers and sets out the regulatory requirements they will need to meet. Bacteriophages are virus-based therapies that could help to combat antimicrobial resistant infections (Shutterstock)

  • Australia Looks To Modernize Human Tissue Laws, Improving Access For Researchers

    5 days ago | insights.citeline.com | Eliza Slawther

    Australia Looks To Modernize Human Tissue Laws, Improving Access For ResearchersAustralia is reviewing its human tissue laws for the first time in almost 50 years, and is hoping to reduce barriers to access for scientific researchers, for instance by addressing issues with access to cell lines for developing drugs. Researchers in Australia could benefit from easier access to human tissue under a revision of existing laws (Shutterstock)

  • EMA Official Clarifies Benefits & Limitations Of Innovation Pathways

    5 days ago | insights.citeline.com | Eliza Slawther

    EMA Official Clarifies Benefits & Limitations Of Innovation PathwaysA European Medicines Agency official provided an overview and update of the support the EMA offers developers of innovative products and discussed, among other things, its Innovation Task Force, Quality Innovation Group and a scientific advice pilot for clinical trials. EMA head of orphan medicines Kristina Larsson presenting virtually at the RAPS Euro Convergence 2025 (Pink Sheet)

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
575
Tweets
1K
DMs Open
No
Eliza Slawther
Eliza Slawther @ElizaSlawther
5 Sep 24

RT @AprioriBio: A new article from @ElizaSlawther in @Citeline’s In Vivo highlights how Apriori is leading the way in the development of va…

Eliza Slawther
Eliza Slawther @ElizaSlawther
16 Aug 24

European First As Vertex’s CRISPR/Cas9 Gene Therapy Casgevy Gets English Funding My article for @PharmaPinkSheet - free to read for non-subscribers https://t.co/F5JwzG7SDJ

Eliza Slawther
Eliza Slawther @ElizaSlawther
6 Aug 24

RT @Citeline: Get started with your free trial to Pink Sheet today: https://t.co/zSNrPdSZjh. https://t.co/SqYTz3l14M